Nursing Perspectives in the Management of Multiple Myeloma

Nursing Perspectives in the Management of Multiple Myeloma is organized by Haymarket Media Group, American Academy of CME, Inc.

Released: September 30, 2020
Expires: September 30, 2021

Target Audience:
This activity is designed for the oncology nurse and nurse practitioner engaged in the care of patients with multiple myeloma. Other team members may also participate.

Accreditation:
American Academy of CME, Inc., designates this educational activity for 1.5 ANCC contact hours (1.2-pharmacotherapeutic contact hours).

California:
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

Description:
The landscape of multiple myeloma therapy is evolving. There is an ongoing need for clinician education as treatment options expand and are integrated into treatment regimens, and guidelines are updated to reflect these advances. Nursing considerations are different with newer agents compared to standard chemotherapy. Additionally, it’s important that clinicians understand the impact of COVID-19 and how to reduce the risk of infection in vulnerable patients.

Objectives Topics
Upon completion of the educational activity, participants should be better able to:
• Identify new medication regimens for the treatment of MM and their tier in therapy
• Describe adverse events and management strategies of medications used to treat MM
• Review the supportive care needs of MM patients based on their medication regimen and co- morbidities
• Describe strategies to reduce the risk of skeletal, thrombotic, and infectious complications in MM